CVE-2026-33057Mesop is a Python-based UI framework that allows users to build web applications.
Updated under an hour ago ()
Does this affect you?
It affects mesop-dev mesop. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
Mesop is a Python-based UI framework that allows users to build web applications. In versions 1.2.2 and below, an explicit web endpoint inside the ai/ testing module infrastructure directly ingests untrusted Python code strings unconditionally without authentication measures, yielding standard Unrestricted Remote Code Execution. Any individual capable of routing HTTP logic to this server block will gain explicit host-machine command rights. The AI codebase package includes a lightweight debugging Flask server inside ai/sandbox/wsgi_app.py. The /exec-py route accepts base_64 encoded raw string payloads inside the code parameter natively evaluated by a basic POST web request. It saves it rapidly to the operating system logic path and injects it recursively using execute_module(module_path...). This issue has been fixed in version 1.2.3.
- CVSS
- 9.8 CRITICAL (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- Weakness (CWE)
- CWE-94
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Analyzed
- Record last updated
- Jun 17, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
mesop-dev mesop mesop-dev:mesop | before 1.2.3 | NVD |
References
- https://github.com/mesop-dev/mesop/commit/825f55970c20686de3f28e2c66df4d74e9d4db47patch
- https://github.com/mesop-dev/mesop/security/advisories/GHSA-gjgx-rvqr-6w6vvendor-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.